Li W - Search Results

1

Anti-tumour effect of neo-antigen-reactive T cells induced by RNA mutanome vaccine in mouse lung cancer.

Sun J, Zhang J, Hu H, Qin H, Liao X, Wang F, Zhang W, Yin Q, Su X, He Y, Li W, Wang K, Li Q. Sun J, et al. Among authors: li w, li q. J Cancer Res Clin Oncol. 2021 Nov;147(11):3255-3268. doi: 10.1007/s00432-021-03735-y. Epub 2021 Jul 21. J Cancer Res Clin Oncol. 2021. PMID: 34291357 Free PMC article.

2

Anti-tumour effect of in situ vaccines combined with VEGFR inhibitors in the treatment of metastatic cervical cancer.

Liu L, Cai L, Du X, Zhao J, Zhao Y, Zou C, Yu S, Zhang C, Ye P, Su X, Yan X, Li W. Liu L, et al. Among authors: li w. Int Immunopharmacol. 2021 Dec;101(Pt B):108302. doi: 10.1016/j.intimp.2021.108302. Epub 2021 Oct 28. Int Immunopharmacol. 2021. PMID: 34717193 Free article.

3

Robust immune response stimulated by in situ injection of CpG/αOX40/cGAMP in αPD-1-resistant malignancy.

Cai L, Du X, Zhang C, Yu S, Liu L, Zhao J, Zhao Y, Zhang C, Wu J, Wang B, Chen Y, Su X, Yan X, Li W. Cai L, et al. Among authors: li w. Cancer Immunol Immunother. 2022 Jul;71(7):1597-1609. doi: 10.1007/s00262-021-03095-z. Epub 2021 Nov 3. Cancer Immunol Immunother. 2022. PMID: 34731284 Free PMC article.

4

Optimization of whole-cell vaccines with CpG/αOX40/cGAMP to strengthen the anti-tumor response of CD4⁺ T cells in melanomas.

Du X, Wu J, Zhao Y, Wang B, Ding X, Lin Q, Chen Y, Zhao J, Liu L, Mao X, Fang Z, Zhang C, Li W. Du X, et al. Among authors: li w. J Cancer Res Clin Oncol. 2022 Dec;148(12):3337-3350. doi: 10.1007/s00432-022-04117-8. Epub 2022 Jun 24. J Cancer Res Clin Oncol. 2022. PMID: 35748951 Free PMC article.

5

Crizotinib synergizes with cisplatin in preclinical models of ovarian cancer.

Huang XX, Xie FF, Hou LJ, Chen XX, Ou RY, Yu JT, Qiu JG, Zhang WJ, Jiang QW, Yang Y, Zheng DW, Chen Y, Huang JR, Wang K, Wei MN, Li WF, Shi Z, Yan XJ. Huang XX, et al. Am J Transl Res. 2017 Apr 15;9(4):1667-1679. eCollection 2017. Am J Transl Res. 2017. PMID: 28469773 Free PMC article.

6

MicroRNA-15b promotes proliferation and invasion of non‑small cell lung carcinoma cells by directly targeting TIMP2.

Wang H, Zhan Y, Jin J, Zhang C, Li W. Wang H, et al. Among authors: li w. Oncol Rep. 2017 Jun;37(6):3305-3312. doi: 10.3892/or.2017.5604. Epub 2017 Apr 26. Oncol Rep. 2017. PMID: 28498424 Retracted.

7

MicroRNA-342 inhibits the progression of glioma by directly targeting PAK4.

Lu X, Wang H, Su Z, Cai L, Li W. Lu X, et al. Among authors: li w. Oncol Rep. 2017 Aug;38(2):1240-1250. doi: 10.3892/or.2017.5783. Epub 2017 Jul 3. Oncol Rep. 2017. PMID: 28677773

8

YM155 enhances docetaxel efficacy in ovarian cancer.

Hou LJ, Huang XX, Xu LN, Zhang YY, Zhao N, Ou RY, Li WF, Zhang WJ, Jiang QW, Yang Y, Wei MN, Huang JR, Wang K, Yuan ML, Xing ZH, Shi Z, Yan XJ. Hou LJ, et al. Am J Transl Res. 2018 Mar 15;10(3):696-708. eCollection 2018. Am J Transl Res. 2018. PMID: 29636860 Free PMC article.

9

Efficacy of apatinib on multiple advanced-stage nongastric cancers.

Wu X, Wang H, Wu Y, Jin J, Zhan Y, Zhu G, Zhang F, Zhang C, Gan J, Li W. Wu X, et al. Among authors: li w. J Cancer Res Ther. 2019;15(4):836-841. doi: 10.4103/jcrt.JCRT_24_19. J Cancer Res Ther. 2019. PMID: 31436240 Free article.

10

Apatinib in patients with extensive-stage small-cell lung cancer after second-line or third-line chemotherapy: a phase II, single-arm, multicentre, prospective study.

Xu Y, Huang Z, Lu H, Yu X, Li Y, Li W, Chen J, Chen M, Gong L, Chen K, Qin J, Xu X, Jin Y, Zhao J, Shi X, Han N, Xie F, Zhang P, Xu W, Fan Y. Xu Y, et al. Among authors: li y, li w. Br J Cancer. 2019 Oct;121(8):640-646. doi: 10.1038/s41416-019-0583-6. Epub 2019 Sep 16. Br J Cancer. 2019. PMID: 31523058 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75,265 results

Search Page